Get more replies from employers
Send a job-specific resume in minutes.
Pharmaron is seeking a Scientist II, Discovery DMPK in Exton, PA for a full-time onsite role. You will lead in vivo PK and in vitro ADME studies, leveraging LC-MS/MS to support drug discovery projects in a fast-paced CRO environment.
The ideal candidate holds a B.S. in a relevant science and has at least two years of hands-on LC-MS/MS experience, with strong scientific writing and the ability to manage multiple priorities while delivering high-quality data.
Position: Scientist II, Discovery DMPK
Salary Range: $55,000-$65,000
Location: Exton, PA (onsite)
Pharmaron is a global contract research and manufacturing organization (CRO/CDMO) helping pharma and biotech companies bring new therapies to life. With over 25,000 employees worldwide across 28 locations in the US, UK, China, and Singapore, we support drug discovery through to manufacturing with fully integrated high-quality services.
We're proud of the impact we make and just last year, we supported 887 discovery projects, 1,100+ CMC programs, and 1,397 clinical trials across all phases. Our teams are involved in everything from small molecules, ADC's, biologics, and gene therapies and we work with more than 3,300 global customers. To learn more, visit www.pharmaron.com.
Are you passionate about advancing drug discovery through innovative bioanalytical science? We're seeking a Scientist I/II to join our growing Discovery DMPK team. In this role, you'll contribute to critical in vivo pharmacokinetic (PK) and in vitro ADME studies, supporting pharmaceutical and biotechnology clients as they develop the next generation of therapeutics. This is an excellent opportunity for an analytical scientist with LC-MS/MS expertise who enjoys working in a collaborative, fast-paced contract research environment where scientific excellence and client service go hand in hand.
Pharmaron is a premier service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities and established a broad spectrum of research, development, and manufacturing service capabilities throughout the entire drug discovery, preclinical, and clinical development process across multiple therapeutic modalities, including